The Festival of Genomics and Biodata is just around the corner, and we’ve had the opportunity to sit down with […] ...

Early-stage lung adenocarcinoma alters DNA methylation, mRNA transcription, and protein expression in adjacent tissues, exhibiting either steep changes at the tumor boundaries or shallow changes ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

In a nascent and fragmented regulatory environment, focusing on the ethical implications of the company’s AI activities is a prudent strategy for board oversight of AI risk.

Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

At the University of Illinois, we’ve discovered that faith and science, united through dialogue and understanding, is our pathway to connect.

TEL AVIV, Israel and NEW YORK, Oct. 15, 2025 /PRNewswire/ -- Celleste Bio™, an early-stage cocoa tech company, announced today a major milestone in building a climate resilient cocoa supply. At this ...

In a video shared on the social media platform X on Thursday, the investor shared his thoughts on the probe into Tesla. "I don't think that they're [NHTSA] going after Tesla per se," the investor said ...

While recent advances in gene therapy have offered unprecedented options for patients with hemophilia, new data presented at the 32nd Annual Congress of the European Society of Gene and Cell Therapy ...